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Abstract
Background: Bone repair is dependent on the presence of osteocompetent progenitors that are able to
differentiate and generate new bone. Muscle is found in close association with orthopaedic injury, however its
capacity to make a cellular contribution to bone repair remains ambiguous. We hypothesized that myogenic cells
of the MyoD-lineage are able to contribute to bone repair.
Methods: We employed a MyoD-Cre
+:Z/AP
+ conditional reporter mouse in which all cells of the MyoD-lineage are
permanently labeled with a human alkaline phosphatase (hAP) reporter. We tracked the contribution of MyoD-
lineage cells in mouse models of tibial bone healing.
Results: In the absence of musculoskeletal trauma, MyoD-expressing cells are limited to skeletal muscle and the
presence of reporter-positive cells in non-muscle tissues is negligible. In a closed tibial fracture model, there was
no significant contribution of hAP
+ cells to the healing callus. In contrast, open tibial fractures featuring periosteal
stripping and muscle fenestration had up to 50% of hAP
+ cells detected in the open fracture callus. At early stages
of repair, many hAP
+ cells exhibited a chondrocyte morphology, with lesser numbers of osteoblast-like hAP
+ cells
present at the later stages. Serial sections stained for hAP and type II and type I collagen showed that MyoD-
lineage cells were surrounded by cartilaginous or bony matrix, suggestive of a functional role in the repair process.
To exclude the prospect that osteoprogenitors spontaneously express MyoD during bone repair, we created a
metaphyseal drill hole defect in the tibia. No hAP
+ staining was observed in this model suggesting that the
expression of MyoD is not a normal event for endogenous osteoprogenitors.
Conclusions: These data document for the first time that muscle cells can play a significant secondary role in
bone repair and this knowledge may lead to important translational applications in orthopaedic surgery.
Please see related article: http://www.biomedcentral.com/1741-7015/9/136
Background
The conventional cellular understanding of the bone
repair process places progenitors originating from the
periosteum and the bone marrow compartment in a
pivotal role. The periosteum, a cellular layer surround-
ing bones, has a well defined capacity for bone repair
[1]. Mesenchymal progenitors from the marrow are also
highly plastic and are involved in bone homeostasis [2].
However, there are many orthopaedic circumstances
where damage to the periosteum, debridement to pre-
vent infection, and internal fixation limit the access by
these primary osteoprogenitors. High-energy traumatic
fractures and open fractures have a much higher relative
risk of non-union [3], yet many can still go on to unite.
Although one possibility is that the periosteal and/or
marrow tissues are able to recover sufficiently to facili-
tate repair, we have hypothesized that secondary pro-
genitor cell types are likely to compensate.
We have recently reviewed a range of progenitor cell
types that may have the potential to contribute to bone
repair [4]. These include cells from the adjacent soft tis-
sues (myogenic progenitors, vascular endothelial cells,
and pericytes) as well as circulating progenitors. Myo-
genic cells represent a strong candidate for contributing
to local bone healing. In cell culture, myogenic cells are
highly responsive to osteogenic growth factors and the
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increased by forced expression of the myogenic factor
MyoD [5]. Muscle-derived cells cultured ex vivo and re-
implanted into mice have been shown to be able to con-
tribute to new bone formation [6,7]. When bone repair
is observed in the clinical orthopaedic setting, the bone
that first forms in response to a fracture is often seen
adjacent to the local muscles [8]. Nevertheless, such
data is only circumstantial and does not specifically
demonstrate that myogenic cells can contribute to bone
formation in an in vivo setting.
One challenge with examining the contribution of dif-
ferent progenitor populations in vivo is tracking their
contribution to other tissues once they have ceased
expressing markers that define their origin. To over-
come this limitation, researchers have started to employ
Cre/loxP conditional reporter systems where early line-
age specification markers can drive a permanent recom-
bination event in all downstream tissues. In this study,
we have utilized a MyoD-Cre mouse line, where the
majority of early myogenic progenitors can be perma-
nently labeled. Prior reports have indicated that the pre-
sence of MyoD-lineage cells in non-muscle tissues is a
rare event [9], and we have confirmed this experimen-
tally (Additional File 1, Additional File 2, Additional File
3). We determined that this would be a suitable model
to examine the contribution of myogenic progenitors to
orthopaedic repair.
MyoD-Cre and Tie2-Cre reporter mice have been pre-
viously employed to study the contribution of endogen-
ous myogenic and vascular progenitors in models of
heterotopic bone formation [10]. Lounev et al reported
that the process of rhBMP-2 induced intramuscular
bone formation featured a negligible contribution by
MyoD-lineage cells, but a major (up to 50%) contribu-
tion by Tie2-lineage cells. However, prior work by Lu et
al indicated a minimal contribution by Tie2-lineage cells
to fracture repair [11], suggesting important fundamen-
tal differences between heterotopic ossification and frac-
ture healing.
In the present study, we have performed a detailed
analysis of the contribution of MyoD-lineage cells to
bone repair in the mouse tibia using a number of surgi-
cal models. First, we compared closed tibial fractures
where the periosteum was largely intact with an open,
highly-traumatic fracture model featuring periosteal
stripping and local tissue trauma. We hypothesized that
the involvement of any secondary repair systems, such
as from the myogenic progenitors, would be greatest
when the periosteal progenitors were deficient. Next, we
examined a drill hole defect model in the proximal tibial
metaphysis where all adjacent muscle tissues were
stripped. Histological staining for the hAP reporter was
used to determine the contribution of the MyoD-lineage
cells to the fracture callus or bone defect. Adjacent sec-
tions were also co-stained for bone/cartilage matrix
markers to confirm the successful transdifferentiation of
t h eo n c em y o g e n i cc e l l si n t ot h eo s t e o g e n i ca n dc h o n -
drogenic lineages.
Methods
Mouse lines
The MyoD-Cre mouse line expresses the Cre recombi-
nase gene under the control of the MyoD promoter
[12]. This mouse line was a gift from A/Prof David
Goldhamer (University of Connecticut, Storrs, CN, Uni-
ted States). In the absence of Cre recombinase, the Z/
AP reporter strain constitutively expresses a lacZ trans-
gene; upon exposure to Cre, the transgene recombines
to express human placental alkaline phosphatase (hAP)
[13]. This mouse line allows specific distinct between
reporter and endogenous expression as hAP is heat-
resistant while endogenous alkaline phosphatase is heat-
labile. This mouse line was supplied by Prof. Patrick
Tam (Children’s Medical Research Institute, Westmead,
NSW, Australia) with permission from Prof. Andras
Nagy (Samuel Lunenfeld Research Institute, Toronto,
Ontario, Canada), who originally published the strain.
The MyoD-Cre mouse line was on a predominantly
C57BL6/J background (> 5 generations backcross) and
the Z/AP line was of a mixed 129/SvJ:C57BL6/J back-
ground. MyoD-Cre
+:Z/AP
+ mice were generated by
breeding mice heterozygous for the transgenes; MyoD-
Cre
-:Z/AP
+ littermates were used as staining controls.
For developmental experiments, transgenic embryos
were produced by timed mating.
Mice were housed at the Children’s Hospital at West-
mead (CHW) Transgenic Facility and at the Westmead
Hospital Department of Animal Care. The health status
of mice was routinely monitored by animal house staff
and mice were given food and water ad libitum. Animal
experimentation was approved by the CHW/CMRI Ani-
mal Ethics Committee (K248) and the Westmead Hospi-
tal Animal Ethics Committee (4102).
Genotyping
Transgenic mice were genotyped using ear or tail DNA
by standard PCR method using Taq polymerase. Tissue
samples were digested with Direct PCR lysis buffer (Via-
gen Biotech, Los Angeles, CA, United States) with
added proteinase K (333 μg/ml) at 55°C for 2 hours to
overnight. Proteinase K activity was terminated by heat-
denaturation at 85°C for 40 min. Samples were run on a
2% TAE agarose gel with ethidium bromide and bands
visualized under UV light (AlphaImager; Quantum
Scientific Pty Ltd, Murarrie, QLD, Australia). The
MyoD-Cre × Z/AP mice were genotyped with primers
for Cre (5’-CATCGTCGGTCCGGGCTGCC-3’ and 3’-
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ATCGCTGATTTGTGTAGTCGGT-3’ and 3’-CAA-
CAGTTGCGCAGCCTGAATG-5’)u s i n gs t a n d a r dP C R
conditions. The genotyping reaction is based on the Taq
DNA polymerase methodology and was prepared
according to the protocol provided by the manufacturer
(Roche Diagnostics, Indianapolis, IN, United States).
Surgical procedures
Tibial fracture
Midshaft tibial fractures were created manually by
three-point bending with surgical stable removers, as
previously reported [14]. Anesthesia was induced by
the intraperitoneal injection of ketamine (35 mg/kg)
and xylazine (4.5 mg/kg). A small incision was made
slightly below the knee and a 30 G needle was
inserted. After the fracture was made, its position was
confirmed using a digital x-ray machine (Faxitron X-
ray Corp., Wheeling, IL, United States). The 30 G nee-
dle was then replaced with a 0.3 mm-diameter stainless
steel insect pin to provide additional stability with
bone end alignment preserved by an experienced sur-
geon and confirmed by x-ray. For closed fractures, no
additional procedures were performed. In open frac-
tures, the fracture site was subsequently opened and
the local periosteum stripped for ~3 mm each side of
the fracture site. To mimic the traumatic soft tissue
injury that is often associated with open fractures, the
muscles surrounding the tibial midshaft was repeatedly
manually fenestrated using magnum 15 tattoo needles.
Wounds were closed using suture material and Vet-
bond as required. Analgesia was again given by s.c.
buprenorphine and mice were monitored daily for the
first 3 days. Fracture repair was monitored by weekly
radiography (Faxitron x-ray) and in the event where
internal fixation had failed (due to pin slippage, bend-
ing or breakage) the affected mouse was culled and
excluded from subsequent analysis. Mice were eutha-
nized for 1, 2 and 3 week time points.
Tibial drill hole
A medial skin incision was made over the proximal
metaphysis of the tibia and the proximal medial tibial
bone surface was exposed by elevating the covering
muscle flap and thorough periosteal stripping. A defect
of 1 mm diameter and 1 mm depth was created in the
proximal metaphysis of the right tibiae using a spherical
1 mm burr and thoroughly rinsed with sterile saline.
After the defect was made, its position was confirmed
by digital x-ray. Subsequently, the muscle flap was
excised and the skin closed directly over the defect leav-
ing the defect without any muscle coverage. Anesthesia
and analgesia were given as described for the tibial frac-
ture model. Mice were euthanized for hind limb harvest
at day 7 after surgery for histochemical staining.
Histochemical and immunohistochemical staining
Human alkaline phosphatase (hAP) staining
Specimens were harvested and processed for cryo-pre-
servation. Samples were initially fixed in 0.25% glutaral-
dehyde at 4°C overnight and then decalcified in 0.4 M
EDTA for 2-3 weeks at 4°C. Samples were then pre-
pared for cryo-preservation by overnight incubation in a
30% sucrose solution, embedded in TissueTek O.C.T.
compound (ProSciTech, Kirwan, QLD, Australia) and
frozen in liquid nitrogen-cooled isopentane. 5 μm sec-
tions were cut on the Leica cryostat and collected on
Superfrost slides (HD Scientific). For staining, samples
were fixed with 4% paraformaldehyde (PFA) in phos-
phate buffered saline (PBS) for 20 min at room tempera-
ture. Slides were washed in PBS and then heat
inactivated at 75°C to eliminate endogenous alkaline
phosphatase staining. A NBT/BCIP solution (Roche
Diagnostics, Cat # 1161451001) was diluted 1:50 in
NBT/BCIP buffer (0.1 M NaCl, 0.1 M Tris-HCl pH 9.4,
0.1 M MgCl2, 0.1% Tween-20) and were used to stain
hAP
+ cells blue, and sections were briefly counterstained
with Nuclear Fast Red. Stained slides were taken
through an alcohol/xylene series and mounted. Z/AP lit-
termates were included in all staining protocols to pro-
duce controls that would stain negative for hAP.
Collagen I and II immunohistochemistry
Collagen I and II antibodies were used to detect mature
bone cells and chondrocytes respectively using standard
protocols. Briefly, cryosections were fixed with 4% PFA
and endogenous peroxides were blocked using 0.3%
H2O2 in methanol at room temperature for 10 min.
Nonspecific binding of immunoglobulin was blocked by
incubating slides in 2% BSA for 20 min. Sections were
incubated with the primary antibodies (Collagen I,
1:200; Collagen II, 1:200) for 2 hours at room tempera-
ture. Sections were incubated with the anti-rabbit sec-
ondary antibody (1:100). All antibodies were purchased
from Abcam. Antibody complexes were detected using
diaminobenzidine (DAB) substrate (Vector Laboratories,
Burlingame, CA, United States). All sections were coun-
terstained with hematoxylin for 15 sec, cleared in etha-
nol and xylene and mounted.
Quantification and statistical analyses
Stained tissue sections were scanned using Scanscope
virtual scanning software (Aperio). Five grids (350 μm×
350 μm
2 in area) were randomly placed around a sec-
tion of fracture callus. The number of positive cells
were counted and expressed as a percentage over the
total number of cells in the grid. Cells are expressed as
percent averages of five sections from three different
animals at the chondrogenic (2 week) and osteogenic (3
week) stages of fracture repair. To quantify the contri-
bution of hAP
+ MyoD-lineage cells to fracture repair,
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shown schematically in Figure 1. The gap between the
two bone ends where the bone was surgically broken
was defined as the fracture gap (F), while the granula-
tion tissue that bridged the fracture site was labeled the
callus area (C). The peri-cortical bone (P) was identified
as the osteoid formed along the bone surface within 150
μm of the tibiae. This region was designated as peri-cor-
tical, as opposed to periosteal, to reflect the surgical
stripping of the cellular periosteum normally present on
t h eb o n es u r f a c ei nt h eo p e nf r a c t u r eg r o u p .A l lc e l l s
within the fracture gap and peri-cortical bone were
counted. Due to the large size of the callus area, grids
(350 μm×3 5 0μm
2 in area) were randomly placed
around the callus region and the number of positive
cells was expressed as a percentage over the total num-
ber of cells in the grid. No cells were counted during
the inflammatory/mesenchymal (1 week) phase of frac-
ture repair.
Due to group numbers being less than 10, stringent
non-parametric statistical tests were employed. The dif-
ferences between multiple treatment groups at each
time point were analyzed using a Kruskal-Wallis test,
and specific groups were compared with a Mann-Whit-
ney U test with values of P ≤ 0.05 considered statisti-
cally significant. Statistical tests were performed using
SPSS Statistics version 17 (SPSS Inc., Chicago, IL, Uni-
ted States).
Results
MyoD-lineage cellular contribution to muscle and non-
muscle tissues
Before performing any bone repair experiments, we per-
formed a detailed study to examine any non-specific or
developmental expression of the MyoD-Cre transgene.
Developmental expression was examined in E13.5, E15.0
and E19.0 MyoD-Cre
+:Z/AP
+ mouse embryos. In
embryo sections, hAP reporter staining was restricted to
the mononuclear precursors surrounding the developing
skeleton (E13.5) and later as multinucleated muscle
fibers (E15.0, E19.0) (Additional File 1). The develop-
mental profile of the hAP reporter indicated a high spe-
cificity for muscle.
A range of tissues from skeletally mature mice were
then stained to examine any leakage of the promoter or
any significant contribution of MyoD-lineage cells to
non-muscle tissues. No hAP reporter positive cells were
observed in any of these tissues, including bone, bone
marrow (Additional File 2), and periosteum (Additional
File 3). These data indicate, under normal developmen-
tal and physiological conditions, that expression of the
MyoD-Cre transgene is restricted to the developing and
mature muscle. Furthermore, muscle fibers were ubiqui-
tously stained, confirming the role of MyoD as a master
regulator of muscle and indicating that a majority of
myogenic cells underwent Cre-mediated recombination.
MyoD-lineage cells contribute to open but not closed
fracture repair
To examine the contribution of MyoD-lineage cells in
models of bone repair, both MyoD-Cre
+:Z/AP
+ mice
and MyoD-Cre
-:Z/AP
+ (Z/AP
+) staining control litter-
mates underwent fracture surgery. Both the closed and
the open tibial fracture models were reproducible and
all animals survived the surgery. Fractures were exam-
ined over a time course of 3 weeks and X-rays illu-
s t r a t e dt h a ta l lf r a c t u r e sw e r eb r i d g e db yw e e k3 .
Fracture repair is rapid in the mouse and studies were
not powered to examine differences in healing rates
between closed and open tibial fractures. Mice with
Figure 1 Schematic representation of the fracture areas used for quantification. For cell counting analyses, regions of the fracture callus
were designated as shown. The fracture gap (F) was defined as the area between the bone ends where the initial impact that broke the
endogenous bone occurred. The peri-cortical bone (P) was defined as the area 150 μm above the endogenous bone and stretched along the
length of the endogenous bone in the four quadrants shown. The callus area (C) was defined as the rest of the newly formed bone that
enveloped the endogenous bone at the breakage point.
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uted fractures were excluded from subsequent analysis.
The closed fracture model produced minimal damage
to the surrounding tissues and featured a largely intact
periosteum. Stained sections showed no or minimal
number of hAP
+ cells throughout the 3 week repair per-
iod. At week 1, few hAP
+ cells were seen in the
mesenchymal template (Figure 2A, arrowhead in 2A’).
From 2 weeks onwards, no labeled cells were observed
(Figure 2B-C). These results indicate that MyoD-lineage
cells make a minimal contribution to closed fracture
healing.
In the open fracture model, the fracture site was
opened surgically and the periosteum stripped from the
cortical bone. The muscle surrounding the tibia was
fenestrated to induce substantive soft tissue trauma. In
contrast to the closed fracture model, a major
contribution by MyoD-lineage cells was observed at all
stages of the fracture repair process. At week 1, numer-
ous hAP
+ cells were noted in the initial mesenchymal
template, particularly in the peri-cortical region (Figure
2D, enlarged in 2D’). This included cells with an elon-
gated mesenchymal morphology (arrow heads) and
rounded cells reminiscent of chondroblasts (small
arrows). By 2 weeks, a soft fracture callus had formed
and cells had the distinctive rounded appearance of
chondrocytes. A large proportion of these cells were
hAP
+ both at the fractured site and throughout the frac-
ture callus (Figure 2E). At 3 weeks, hAP
+ osteoblasts
w e r es e e no nt h eb o n es u r f a c ea n dh A P
+ osteocytes
were observed embedded in the immature woven bone.
The reporter positive cells at week 3 were mainly pre-
sent in the callus interior, and the exterior remained
mainly reporter negative (Figure 2F).
Figure 2 MyoD-lineage cells contribute to open but not closed fracture repair. Histologically, only the occasional hAP
+ labeled cell was
detected in the early repair matrix in the closed fracture model (arrowhead in A’). No contribution from MyoD cells were seen in the latter
stages of closed fracture repair (B-C). In the open fracture model, hAP
+ cells resembling mesenchymal cells (arrowheads) and chondroblasts
(arrows) were observed in the 1 week fracture template (D, enlarged in D’). Numerous hAP
+ cells were visible in the fracture callus at 2 weeks
(E) and although reporter expression decreased by 3 weeks, hAP
+ labeled cells were still observed (F). No staining was observed in endogenous
bone, or in the fracture calluses of Z/AP control mice (G-I). Scale bar = 100 μm.
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samples taken from mice possessing only the Z/AP
transgene (Figure 2G-I). This indicates that heat inacti-
vation of endogenous alkaline phosphatase was complete
and that all enzymatic staining was specific to the
MyoD-Cre and Z/AP transgenes. As an additional inter-
nal control, no hAP reporter staining was observed in
any of the non-fractured bone of MyoD-Cre
+:Z/AP
+
mice in either the closed or open fracture models.
To quantify the contribution of MyoD-lineage cells to
open and closed fracture healing, whole callus sections
w e r ed i g i t a l l yi m a g e du s i n gaS c a n s c o p es l i d es c a n n e r .
Regional quantification was performed in week 2 and
week 3 healing fractures (Table 1). For open fractures,
the greatest contribution was seen in areas of early bone
repair such as in the fracture gap where up to 53% of
cells were hAP
+. Reporter cell numbers were found to
decrease in areas away from the initial fracture and also
decrease over time.
To examine whether the MyoD-lineage cells were
having a productive role in the bone healing process,
hAP
+ cells found in areas of bone and cartilage were
co-stained for bone/cartilage markers (type I or type II
collagen) on serial sections. Immunohistochemical
staining confirmed that hAP
+ labeled cells had pro-
gressed to express characteristic cartilage and bone
extracellular matrix proteins (Figure 3).
Endogenous osteoprogenitors do not express MyoD
during bone defect repair
The aforementioned experiments suggested that MyoD-
lineage cells from the muscle migrated and repaired
open fractures in the absence of other osteocompetent
cells. An alternative scenario was that cells within open
fractures originating from the bone spontaneously
expressed MyoD during osteogenic differentiation. To
exclude this possibility, we performed a drill hole defect
where local muscle was physically stripped and endo-
genous osteoprogenitors were plentiful. In this system
no staining was observed within the healing defects
(Figure 4).
Discussion
These orthopaedic bone repair studies offer new and
valuable perspectives on the capacity of MyoD-lineage
cells to contribute to bone formation and fracture
repair. While the conditions associated with recalcitrant
fracture repair are well described on a physiological
level, the specific cell types that normally contribute to
these processes remain poorly defined. Many lineage
tracing studies described in the literature are compli-
cated by issues of transient reporter expression. In the
current study, the Cre/loxP system was adopted to per-
manently label MyoD-lineage cells and effectively track
Table 1 MyoD-lineage contribution to open fracture
repair (% of hAP+ cells)
Fracture location
Fracture gap (F) Peri-cortical bone (P) Callus area (C)
2 week 53.9 ± 4.7 40.0 ± 2.0 35.9 ± 4.5
3 week 47.0 ± 4.7 21.3 ± 2.0 13.2 ± 1.3
Figure 3 hAP
+ cells express chondrogenic and osteogenic markers. Serial sections were stained for hAP
+ cells (A, B) and type II collagen in
fractures at week 2 (A’) or type I collagen in the peri-cortical region of open fracture samples at week 3 (B’). Collagen staining was seen in both
the cells and the matrix. hAP
+ cells were found to stain with collagen markers (arrowheads) indicating that formally myogenic progenitors had
contributed to mature cartilage/bone tissue. Scale bar = 50 μm.
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formed using the ROSA26R reporter strain (data not
shown), however false positive staining in osteoclasts
emerged as a significantly confounding factor [15]. The
Z/AP reporter strain proved to be a superior system
with negligible background in adult mouse bone.
Expression of hAP in MyoD-lineage cells did not appear
to impair or augment fracture healing based on union
or callus size by x-ray.
The MyoD-Cre reporter mouse line was selected due
to its apparent specificity to myogenic cells. MyoD is a
specific marker of myogenic cells and is expressed in
the embryonic myotome from as early as embryonic day
9.5 (E9.5) [16]. In muscle satellite cells, MyoD expres-
sion is initiated after satellite cell activation [17-19],
however recent work by Kanisicak et al., demonstrated
that all satellite cell progenitors pass through a MyoD-
expressing stage sometime during their developmental
history [20]. While Goldhamer et al reported rare stain-
ing in skeletal tissues including the perichondrium and
several osteocytes, it is unclear whether this was due to
transgene “leakiness” or due to a rare early developmen-
tal transdifferentiation event involving the MyoD-lineage
[12]. Nevertheless, our staining in embryonic and adult
tissues found transgene expression to be highly
restricted to the muscle (Additional Files 1 and 2) and
not in the periosteum of adult mice (Additional File 3).
Muscle flaps are often used in orthopaedic surgery
and the beneficial effects of muscle proximity to fracture
healing are often attributed to the high vascularity of
this tissue. In contrast, we have hypothesized that in
fracture repair muscle may make a direct cellular contri-
bution to bone, acting as a “secondary periosteum” in
instances where the periosteum itself is damaged or
absent [4]. To test this, we utilized two fracture models:
a closed fracture model where the periosteum was
largely intact and an open fracture where the bone was
denuded of the periosteum with the adjacent muscle
damaged.
Consistent with our hypothesis, MyoD-lineage cells
made substantial contributions to every stage of the
open fracture repair cascade. The greatest number of
hAP
+ cells in the fractured bones were located in areas
closest to the initial site of impact (i.e., at the fracture
gap > peri-cortical bone > external callus area) (Table
1). This could suggest that MyoD-lineage cells are one
of the first cell types to migrate to the site of injury due
to their close proximity to the fractured bone. The con-
comitant muscle trauma may facilitate the passage of
MyoD-lineage cells through injured fascial compart-
ments to the fracture site. The proportion of reporter
positive cells in open fractures were found to decrease
with time, suggesting that myogenic progenitors can act
in the initial bone healing response, but are less involved
with subsequent bone remodeling. A model by Harry et
al. has demonstrated functional benefits for access to
the adjacent muscle during mouse tibial fracture healing.
When muscle access was physically excluded using a
polymer sheath, this strongly reduced fracture healing
despite adequate or increased vascularity over exclusion
of fasciocutaneous tissue [21,22].
In contrast to the traumatic open fracture scenario,
MyoD-lineage cells made an insignificant contribution
to closed fracture repair. This may suggest that an intact
periosteum can act as a physical barrier to prevent the
invasion of myogenic progenitors, and also strengthens
the concept that periosteal cells contributing to repair
do not transiently express MyoD. The periosteum is a
highly osteogenic tissue and, when present, its contribu-
tion to bone healing is sufficient and does not require
alternative osteoprogenitor sources. The lack of hAP
+
cells in closed fractures also argues against the
Figure 4 Endogenous osteoprogenitors do not express MyoD during tibial defect repair. Decalcified sections from drill hole defects (day 7
of repair) were stained for hAP+ cells. No MyoD-lineage cells were present within the defect (A, A’) but were present within the tibialis anterior
muscle (A).
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transgene by nascent osteoprogenitor populations
responsible for repair (including periosteal cells, Addi-
tional File 3). To further examine whether MyoD-line-
age cells could migrate into and contribute to bone
healing, we tested a tibial defect model where the adja-
cent musculature had been stripped. No hAP+ staining
cells were observed in the healing defect supporting the
hypothesis that muscle accessibility is important for the
contribution of MyoD-lineage cells.
Conclusion
In summary, these studies show for the first time that a
population or sub-population of myogenic progenitors of
the MyoD-lineage can make a significant cellular contribu-
tion to bone repair. In a fracture repair setting, this
required disruption of the periosteum and trauma to the
local tissues. In a defect repair setting, this required direct
access to the muscle. These data suggest that the recruit-
ment of MyoD-lineage cells can be highly dependent on
t h en a t u r ea n dl o c a t i o no ft h eb o n ei n j u r y .E v e ni nt h es u r -
gical mouse models with the greatest myogenic progenitor
contribution, approximately half of the cells originated
from non-myogenic lineages. Thus cell lineages other than
myogenic cells including vascular cells are also likely to
have a major role in bone formation and repair [23].
Apart from scientific clarification of the cellular con-
tribution to bone repair in other orthopaedic models,
future studies can aim to manipulate the surgical sys-
tems with the aim of maximizing MyoD-lineage cell
access and mobilization to augment repair. Methods
which optimize the contribution of secondary (non-peri-
osteal) osteoprogenitors may be translatable to clinical
practice and play a future role in improving the union
rates of high energy and open fractures.
Additional material
Additional file 1: MyoD-lineage cells are developmentally restricted
to the musculature. Strong hAP staining was observed in mononuclear
cells surrounding the developing skeleton at E13.5 (A). As development
progressed, these cells fused into multinucleated myofibers surrounding
the ribs (B) and the developing limb buds (C). No hAP
+ cells were
observed in any skeletal elements throughout the developmental time
frames studied. hAP expression was limited to the muscles of skeletally
mature mice (D) and no staining was observed in any bony elements (E).
Scale bar = 100 μm.
Additional File 2: MyoD-lineage cells do not contribute to adult
non-muscle tissues. No hAP staining was found in non-muscle tissues
including kidney (A), liver (B), lung (C), spleen (D), and heart (E). Strong
and universal staining was observed in all skeletal muscle fibers (F).
Additional File 3: MyoD-lineage cells are not found in the
periosteum. No hAP staining was seen in the periosteum (arrowheads),
underlying bone (B) or bone marrow (BM). The adjacent muscle (M)
stained positive.
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